Barba-Rosado Lemy Vanessa, Carrascal-Hernández Domingo César, Insuasty Daniel, Grande-Tovar Carlos David
Grupo de Investigación en Fotoquímica y Fotobiología, Programa de Química, Facultad de Ciencias Básicas, Universidad del Atlántico, Puerto Colombia 081008, Colombia.
Departamento de Química y Biología, División de Ciencias Básicas, Universidad del Norte, Km 5 Vía Puerto Colombia, Barranquilla 081007, Colombia.
Nanomaterials (Basel). 2024 Jan 13;14(2):186. doi: 10.3390/nano14020186.
Cancer is a severe disease that, in 2022, caused more than 9.89 million deaths worldwide. One worrisome type of cancer is bone cancer, such as osteosarcoma and Ewing tumors, which occur more frequently in infants. This study shows an active interest in the use of graphene oxide and its derivatives in therapy against bone cancer. We present a systematic review analyzing the current state of the art related to the use of GO in treating osteosarcoma, through evaluating the existing literature. In this sense, studies focused on GO-based nanomaterials for potential applications against osteosarcoma were reviewed, which has revealed that there is an excellent trend toward the use of GO-based nanomaterials, based on their thermal and anti-cancer activities, for the treatment of osteosarcoma through various therapeutic approaches. However, more research is needed to develop highly efficient localized therapies. It is suggested, therefore, that photodynamic therapy, photothermal therapy, and the use of nanocarriers should be considered as non-invasive, more specific, and efficient alternatives in the treatment of osteosarcoma. These options present promising approaches to enhance the effectiveness of therapy while also seeking to reduce side effects and minimize the damage to surrounding healthy tissues. The bibliometric analysis of photothermal and photochemical treatments of graphene oxide and reduced graphene oxide from January 2004 to December 2022 extracted 948 documents with its search strategy, mainly related to research papers, review papers, and conference papers, demonstrating a high-impact field supported by the need for more selective and efficient bone cancer therapies. The central countries leading the research are the United States, Iran, Italy, Germany, China, South Korea, and Australia, with strong collaborations worldwide. At the same time, the most-cited papers were published in journals with impact factors of more than 6.0 (2021), with more than 290 citations. Additionally, the journals that published the most on the topic are high impact factor journals, according to the analysis performed, demonstrating the high impact of the research field.
癌症是一种严重的疾病,2022年在全球导致了超过989万人死亡。一种令人担忧的癌症类型是骨癌,如骨肉瘤和尤因肉瘤,在婴儿中更为常见。本研究显示了对氧化石墨烯及其衍生物在骨癌治疗中的应用的积极兴趣。我们通过评估现有文献,对与氧化石墨烯在骨肉瘤治疗中的应用相关的当前技术水平进行了系统综述。从这个意义上说,我们回顾了专注于基于氧化石墨烯的纳米材料在骨肉瘤潜在应用方面的研究,结果表明,基于其热活性和抗癌活性,通过各种治疗方法使用基于氧化石墨烯的纳米材料来治疗骨肉瘤具有良好的趋势。然而,需要更多的研究来开发高效的局部治疗方法。因此,建议光动力疗法、光热疗法和纳米载体的使用应被视为骨肉瘤治疗中无创、更具特异性和高效的替代方法。这些选择提供了有前景的方法来提高治疗效果,同时也寻求减少副作用并将对周围健康组织的损害降至最低。对2004年1月至2022年12月氧化石墨烯和还原氧化石墨烯的光热和光化学处理进行的文献计量分析,通过其搜索策略提取了948篇文献,主要涉及研究论文、综述论文和会议论文,这表明该领域受到对更具选择性和高效的骨癌治疗方法的需求的支持,具有很高的影响力。引领该研究的主要国家有美国、伊朗、意大利、德国、中国、韩国和澳大利亚,全球范围内有很强的合作。同时,被引用次数最多的论文发表在2021年影响因子超过6.0的期刊上,被引用次数超过290次。此外,根据所进行的分析,发表该主题文章最多的期刊都是高影响因子期刊,这表明了该研究领域的高影响力。
Nanomaterials (Basel). 2024-1-13
Early Hum Dev. 2020-11
Cochrane Database Syst Rev. 2022-2-1
J Med Internet Res. 2018-4-18
Niger J Clin Pract. 2023-1
Cancer Cell Int. 2025-5-25
Beilstein J Nanotechnol. 2025-3-3
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025-1-15
J Cancer Res Clin Oncol. 2024-8-22
Molecules. 2024-7-10
Int Immunopharmacol. 2023-12
Int J Biol Macromol. 2023-8-1